|
Volumn 42, Issue 11, 2003, Pages 777-780
|
The effect of proton pump inhibitor on intragastric acidity and it relation to S-mephenytoin hydroxylase genetic polymorphism
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;
ANTIULCER AGENT;
BENZIMIDAZOLE DERIVATIVE;
CYP2C19 PROTEIN, HUMAN;
ENZYME INHIBITOR;
MIXED FUNCTION OXIDASE;
OMEPRAZOLE;
PROTON PUMP;
RABEPRAZOLE;
UNSPECIFIC MONOOXYGENASE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ANTAGONISM;
DUODENUM ULCER;
FEMALE;
GENETIC POLYMORPHISM;
GENETICS;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
STOMACH PH;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ADOLESCENT;
ADULT;
AGED;
ANTI-ULCER AGENTS;
ARYL HYDROCARBON HYDROXYLASES;
BENZIMIDAZOLES;
DUODENAL ULCER;
ENZYME INHIBITORS;
FEMALE;
GASTRIC ACIDITY DETERMINATION;
HUMANS;
MALE;
MIDDLE AGED;
MIXED FUNCTION OXYGENASES;
OMEPRAZOLE;
POLYMORPHISM, GENETIC;
PROTON PUMPS;
|
EID: 2142702800
PISSN: 05781426
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|